Guardant Health, Inc. Quarterly Operating Income (Loss) in USD from Q3 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Guardant Health, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2017 to Q3 2024.
  • Guardant Health, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$117M, a 3.33% decline year-over-year.
  • Guardant Health, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$515M, a 0.35% decline year-over-year.
  • Guardant Health, Inc. annual Operating Income (Loss) for 2023 was -$565M, a 3.74% decline from 2022.
  • Guardant Health, Inc. annual Operating Income (Loss) for 2022 was -$544M, a 32.5% decline from 2021.
  • Guardant Health, Inc. annual Operating Income (Loss) for 2021 was -$411M, a 61.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$515M -$117M -$3.79M -3.33% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$511M -$101M +$19M +15.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$530M -$99.7M +$34.4M +25.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$565M -$198M -$51.4M -35.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 -$513M -$114M +$31.1M +21.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$544M -$120M +$10.7M +8.21% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$555M -$134M -$10.7M -8.69% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$544M -$146M -$47.9M -48.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 -$496M -$145M -$37.3M -34.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$459M -$130M -$32.7M -33.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 -$426M -$123M -$15.5M -14.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$411M -$98.2M -$7.04M -7.72% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-22
Q3 2021 -$404M -$107M -$33M -44.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$371M -$97.6M -$43M -78.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$328M -$108M -$73M -209% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$255M -$91.2M -$65.2M -251% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$190M -$74.3M -$56.8M -325% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$133M -$54.6M -$39.4M -258% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$93.6M -$34.9M -$11.2M -47.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$82.4M -$26M +$1.43M +5.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 -$83.8M -$17.5M +$6.73M +27.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$90.5M -$15.3M +$7.44M +32.7% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$98M -$23.7M -$5.02M -26.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$92.9M -$27.4M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$24.2M +$4.47M +15.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$22.7M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$18.6M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q3 2017 -$28.7M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.